Oregon Administrative Rules › Chapter 855 - BOARD OF PHARMACY › Division 80 - SCHEDULE OF CONTROLLED SUBSTANCES › Section 855-080-0100 - Animal Euthanasia

Current through Register Vol. 63, No. 7, July 1, 2024
(1) The following
			 requirements shall be met in order for a humane society or animal control
			 agency to be registered or registration renewed to allow the purchase,
			 possession and administration of sodium pentobarbital and sedative and
			 analgesic medications for euthanizing injured, sick, homeless or unwanted
			 domestic pets and other animals:
(a)
			 Registration. Registration as an animal euthanasia drug outlet is limited to
			 animal control agencies and humane societies for the purpose of purchasing,
			 possessing, or administering sodium pentobarbital and sedative and analgesic
			 medications to euthanize animals. The outlet must identify and provide to the
			 Oregon Board of Pharmacy via application, a designated representative who will
			 serve as the primary contact person responsible for managing the outlet
			 operations. The outlet shall notify the Board within 15 days of any change in
			 designated representative. Registration requires submission of an application,
			 and a certificate of registration will be issued upon approval. All
			 registrations and renewals shall be accompanied by an annual fee defined in
			 Division 110 of this Chapter.
(b)
			 Drug Storage. All supplies of sodium pentobarbital and sedative and analgesic
			 medications shall be acquired from an Oregon registered distributor, and kept
			 in a locked cabinet. An assigned person designated in writing shall be
			 responsible for the security of the sodium pentobarbital and sedative and
			 analgesic medications. Such designated person shall allow access to and
			 withdrawal of the drug only to a person certified by the Oregon State
			 Veterinary Medical Examining Board to administer sodium pentobarbital and
			 sedative and analgesic medications;
(c) Records. The following records shall be
			 made at the time of the occurrence and shall be maintained for a minimum of
			 three years, available for inspection by the Board of Pharmacy and its agents:
(A) A record of the withdrawal of sodium
			 pentobarbital and sedative and analgesic medications, signed by the person who
			 takes possession of the sodium pentobarbital and sedative and analgesic
			 medications for administration;
(B)
			 A record of the weight, species of animal and dosage of each drug administered
			 for euthanasia signed by the person who administers the drug and by the
			 designated person responsible for security;
(C) A record of all wastage of each drug
			 signed by the person administering the each drug and the designated person
			 responsible for security; and
(D) A
			 weekly record of verification of the amount of each drug on hand, minus the
			 amounts withdrawn for administration, signed by the designated person
			 responsible for security;
(E) A
			 record of disposal of any expired or unwanted sodium pentobarbital and sedative
			 and analgesic medications. Disposal shall be in conformance with federal
			 regulations.
(F) Complete the
			 annual Self-Inspection form by February 1 each year, and retain for Board
			 inspection.
(d) Audits.
			 The registrant shall submit to random audits of records and analysis of
			 prepared solutions by the Drug Enforcement Administration (DEA), and Board of
			 Pharmacy or its agents.